drugset / Trial / NCT03610035

A Study of NPT189 in Healthy Subjects

NCT03610035 ↗

Phase 1 Completed 48 enrolled Proclara Biosciences, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to evaluate the safety and tolerability of single dose of NPT189 in healthy volunteers. The study will also evaluate the pharmacokinetic characteristics of NPT189.

Timeline

Start
2018-07-24
Primary completion
2019-02-17
Completion
2019-02-17

Drugs

EvaluationDrugModalityDoseRoute
Subject NPT189 Protein / enzyme biologic — Intravenous

Indications